Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Alhazzani, F. Alenezi, R. Jaeschke, P. Moayyedi, D. Cook (2012)
Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients: A Systematic Review and Meta-Analysis*Critical Care Medicine, 41
Device associated module: ventilator associated events
A. Localio, D. Margolis, J. Berlin (2007)
Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression.Journal of clinical epidemiology, 60 9
T. Miano, Marc Reichert, T. Houle, D. MacGregor, E. Kincaid, D. Bowton (2009)
Nosocomial pneumonia risk and stress ulcer prophylaxis: a comparison of pantoprazole vs ranitidine in cardiothoracic surgery patients.Chest, 136 2
M. Barbateskovic, S. Marker, A. Granholm, C. Anthon, M. Krag, J. Jakobsen, A. Perner, J. Wetterslev, M. Møller (2019)
Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysisIntensive Care Medicine, 45
C. Aybay, T. Imir, H. Okur (1995)
The effect of omeprazole on human natural killer cell activity.General pharmacology, 26 6
S. Marker, A. Perner, J. Wetterslev, M. Krag, T. Lange, M. Wise, M. Borthwick, S. Bendel, F. Keus, A. Guttormsen, J. Schefold, M. Møller (2019)
Pantoprazole prophylaxis in ICU patients with high severity of disease: a post hoc analysis of the placebo-controlled SUP-ICU trialIntensive Care Medicine, 45
R. MacLaren, Paul Reynolds, R. Allen (2014)
Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.JAMA internal medicine, 174 4
M. Krag, A. Perner, J. Wetterslev, M. Wise, M. Borthwick, S. Bendel, C. McArthur, D. Cook, N. Nielsen, P. Pelosi, F. Keus, A. Guttormsen, A. Moller, M. Møller, the co-authors (2015)
Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patientsIntensive Care Medicine, 41
A. Forbes, M. Akram, D. Pilcher, J. Cooper, R. Bellomo (2015)
Cluster randomised crossover trials with binary data and unbalanced cluster sizes: Application to studies of near-universal interventions in intensive careClinical Trials, 12
Days Until Discharge Alive From Index Hospitalization
B. Bateman, Katsiaryna Bykov, N. Choudhry, S. Schneeweiss, J. Gagne, J. Polinski, J. Franklin, M. Doherty, M. Fischer, J. Rassen (2013)
Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort studyThe BMJ, 347
(2019)
Statistical analysis plan for the PEPTIC study (version 1)
Ramalinga Kedika, R. Souza, S. Spechler (2009)
Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical ImplicationsDigestive Diseases and Sciences, 54
E. Litton, G. Eastwood, R. Bellomo, R. Beasley, M. Bailey, A. Forbes, D. Gattas, D. Pilcher, S. Webb, S. McGuinness, M. Saxena, C. McArthur, P. Young (2014)
A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 16 3
M. Begg, M. Parides (2003)
Separation of individual‐level and cluster‐level covariate effects in regression analysis of correlated dataStatistics in Medicine, 22
E. Capodicasa, F. Bellis, M. Pelli (1999)
Effect of lansoprazole on human leukocyte function.Immunopharmacology and immunotoxicology, 21 2
M. Krag, S. Marker, A. Perner, J. Wetterslev, M. Wise, J. Schefold, F. Keus, A. Guttormsen, S. Bendel, M. Borthwick, T. Lange, B. Rasmussen, M. Siegemund, H. Bundgaard, T. Elkmann, Jacob Jensen, Rune Nielsen, L. Liboriussen, M. Bestle, Jeanie Elkjær, D. Palmqvist, M. Bäcklund, J. Laake, P. Bådstøløkken, J. Grönlund, Olena Breum, A. Walli, R. Winding, Susanne Iversen, I. Jarnvig, J. White, B. Brand, M. Madsen, Lars Quist, K. Thornberg, A. Møller, J. Wiis, A. Granholm, C. Anthon, T. Meyhoff, P. Hjortrup, S. Aagaard, J. Andreasen, C. Sørensen, Pernille Haure, Jacob Hauge, A. Hollinger, Jonas Scheuzger, D. Tuchscherer, Thierry Vuilliomenet, J. Takala, S. Jakob, M. Vang, Kim Pælestik, K. Andersen, I. Horst, W. Dieperink, J. Fjølner, C. Kjer, C. Sølling, C. Sølling, Johanna Karttunen, Matt Morgan, Brit Sjøbø, Janus Engstrøm, B. Agerholm-Larsen, M. Møller (2018)
Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICUThe New England Journal of Medicine, 379
G. Eastwood, E. Litton, R. Bellomo, M. Bailey, M. Festa, R. Beasley, P. Young (2014)
Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 16 3
P. Young, S. Bagshaw, A. Forbes, A. Nichol, S. Wright, R. Bellomo, M. Bailey, R. Beasley, G. Eastwood, M. Festa, D. Gattas, F. Haren, E. Litton, P. Mouncey, L. Navarra, D. Pilcher, D. Mackle, C. McArthur, S. McGuinness, M. Saxena, S. Webb, K. Rowan (2018)
A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 20 3
J. Vincent, J. Marshall, S. Ñamendys-Silva, B. François, I. Martín-Loeches, J. Lipman, K. Reinhart, M. Antonelli, P. Pickkers, H. Njimi, E. Jimenez, Y. Sakr (2014)
Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit.The Lancet. Respiratory medicine, 2 5
Emily Smith, Mary White, Hannah Weir, L. Peipins, Trevor Thompson (2011)
Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United StatesCancer Causes & Control, 23
Key PointsQuestionWhat is the comparative effect on in-hospital mortality of using proton pump inhibitors (PPIs) vs histamine-2 receptor blockers (H2RBs) for stress ulcer prophylaxis among adults requiring invasive mechanical ventilation in the intensive care unit (ICU)? FindingsIn this cluster crossover randomized clinical trial, 26 982 patients requiring invasive mechanical ventilation within 24 hours of ICU admission were randomized by site at 50 ICUs in 5 countries to a PPI strategy or an H2RB strategy for stress ulcer prophylaxis. In-hospital mortality was 18.3% for patients treated at sites randomized to PPI use vs 17.5% for those treated at sites randomized to H2RB use, a difference that did not reach statistical significance (P = .054). Among patients treated at sites randomized to PPIs, 4.1% received H2RBs; among patients treated at sites randomized to H2RBs, 20.1% received PPIs. MeaningA strategy of use with PPIs vs H2RBs for stress ulcer prophylaxis among adults requiring mechanical ventilation did not result in a statistically significant difference for in-hospital mortality, but study interpretation may be limited by crossover in medication use.
JAMA – American Medical Association
Published: Feb 18, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.